Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive ureidopiperidines

J L Archibald, D R Beardsley, G M Bisset

    Journal of Medicinal Chemistry
    |August 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Characterization of <i>Fusarium</i> Species Composition, Trichothecene Genotype, and In Planta and In Vitro Fungicide Sensitivity of Isolates from Wheat and Corn in Michigan, United States.

    Phytopathology·2025
    Same author

    Generating Clinical-Grade Gene-Disease Validity Classifications Through the ClinGen Data Platforms.

    Annual review of biomedical data science·2024
    Same author

    Current use of drains and management of seroma following mastectomy and axillary surgery: results of a United Kingdom national practice survey.

    Breast cancer research and treatment·2023
    Same author

    Species diversity and mycotoxin production by members of the Fusarium tricinctum species complex associated with Fusarium head blight of wheat and barley in Italy.

    International journal of food microbiology·2021
    Same author

    Innovations for the future of breast surgery.

    The British journal of surgery·2021
    Same author

    British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021.

    The British journal of dermatology·2021
    Same journal

    Charting New Territory: Systematic Evaluation of the Drug Potential of <i>N</i>-Trifluoromethyl Amides, Ureas & Carbamates.

    Journal of medicinal chemistry·2026
    Same journal

    Red-Light-Triggered <i>In Vitro</i> and <i>In Vivo</i> Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

    Journal of medicinal chemistry·2026
    Same journal

    Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

    Journal of medicinal chemistry·2026
    Same journal

    HsClpP-Engaging Selective Mitochondrial Pan-PDK Degraders for Cancer Therapy.

    Journal of medicinal chemistry·2026
    Same journal

    Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

    Journal of medicinal chemistry·2026
    Same journal

    Recent Highlights in the Discovery and Design of Antibody-Drug Conjugates.

    Journal of medicinal chemistry·2026
    See all related articles

    Researchers synthesized novel 1-aralkyl-4-ureidopiperidines, finding some exhibit superior antihypertensive activity compared to benzamidopiperidines. Compounds 19 and 58 showed the most significant blood pressure-lowering effects in this new class of drugs.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology

    Background:

    • Benzamidopiperidines, like indoramin, are known for their pharmacological effects.
    • Piperidine derivatives are a key structural class in drug discovery.

    Purpose of the Study:

    • To synthesize and evaluate a novel series of 1-aralkyl-4-ureidopiperidines.
    • To compare the antihypertensive potency of these new compounds with existing benzamidopiperidines.

    Main Methods:

    • Chemical synthesis of 1-aralkyl-4-ureidopiperidine analogs.
    • Pharmacological evaluation of antihypertensive activity in vitro and/or in vivo.

    Main Results:

    • Successful synthesis of a series of 1-aralkyl-4-ureidopiperidines.
    • Identified several ureidopiperidines with enhanced antihypertensive potency over benzamidopiperidines.

    Related Experiment Videos

  • Compounds 19 and 58 demonstrated the highest potency within the studied series.

    • Conclusions:

    • 1-Aralkyl-4-ureidopiperidines represent a promising scaffold for developing new antihypertensive agents.
    • The structural modifications led to improved efficacy compared to related drug classes.
    • Further investigation of compounds 19 and 58 is warranted for potential therapeutic applications.